Double blinded trials can't be stopped early due to "overwhelming signs" of significance as the efficacy data is unknown until all have been through the treatment and then the data becomes known. Based on what ive seen before, it could be a legitimate pause (blame COVID), could be drug supply issues (another pause), pure lack of volunteers, or that the safety monitoring board have seen something in the blood work which warrants halting the trial. i don't think any scenario is a positive. If its just a legit pause, fine, but its still a negative. The IR in this co is absolutely woeful. Be very interesting come AGM time. PR is in for a rough day
- Forums
- ASX - By Stock
- Sass
Double blinded trials can't be stopped early due to...
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
24.0¢ |
Change
-0.005(2.04%) |
Mkt cap ! $83.98M |
Open | High | Low | Value | Volume |
25.0¢ | 25.5¢ | 24.0¢ | $202.2K | 814.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 181098 | 24.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
25.0¢ | 118621 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 118000 | 0.240 |
4 | 27745 | 0.235 |
1 | 25000 | 0.230 |
2 | 6262 | 0.225 |
6 | 48629 | 0.220 |
Price($) | Vol. | No. |
---|---|---|
0.250 | 64601 | 3 |
0.255 | 50000 | 1 |
0.260 | 21333 | 2 |
0.265 | 69367 | 4 |
0.270 | 53000 | 2 |
Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online